Skip to main content
Displaying 401 - 410 of 4028
# Title Department Research Year
401 Novel indazole derivatives as potent apoptotic antiproliferative agents by multi-targeted mechanism: Synthesis and biological evaluation Department of Pharmaceutical Organic Chemistry 2022
402 Novel piperine-carboximidamide hybrids: design, synthesis, and antiproliferative activity via a multi-targeted inhibitory pathway Department of Pharmaceutical Organic Chemistry 2022
403 Novel Spiro Hybrids of 2-indolinone and Thiazolodinone Scaffolds as Cell Cycle Checkpoints’ Pathways Regulators with potential anticancer activity Department of Medicinal Chemistry 2022
404 Nucleic acids for gene therapy (book chapter) Department of Pharmaceutics 2022
405 Optimization and SAR investigation of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as EGFR and BRAFV600E dual inhibitors with potent antiproliferative and antioxidant activities Department of Pharmaceutical Organic Chemistry 2022
406 Perceptions and Attitudes of Hospital’ Prescribers towards Drug Information Sources and Prescribing Practices Department of Clinical Pharmacy 2022
407 Pharmacokinetics and Pharmacodynamics of Dexmedetomidine Administered as an Adjunct to Bupivacaine for Transversus Abdominis Plane Block in Patients Undergoing Lower Abdominal Cancer Surgery Department of Clinical Pharmacy 2022
408 Phytochemical investigation, molecular docking studies and DFT calculations on the antidiabetic and cytotoxic activities of Gmelina philippensis CHAM. Department of Medicinal Chemistry 2022
409 Phytoconstituents from Adenanthera pavonina L. as antioxidants and inhibitors of inducible TNF-a production in BV2 cells Department of Pharmacognosy 2022
410 Prodrugs of non-steroidal anti-inflammatory drugs (NSAIDs) and Amino acid esters as novel non-cyclooxygenase inhibitors for colorectal cancer chemoprevention 2022